作者：
Ackert, Jessica [1]
;
Mohamed, Khadeeja [2]
;
Slakter, Jason S. [3]
;
El-Harazi, Sherif [4]
;
Berni, Alessandro [5]
;
Gevorkyan, Hakop [6]
;
Hardaker, Elizabeth [7]
;
Hussaini, Azra [8]
;
Jones, Sion W. [9]
;
Koh, Gavin C. K. W. [10]
;
Patel, Jyoti [11]
;
Rasmussen, Scott [12]
;
Kelly, Deborah S. [13]
;
Baranano, David E. [14]
;
Thompson, John T. [15]
;
Warren, Keith A. [16]
;
Sergott, Robert C. ;
Tonkyn, John ;
Wolstenholme, Allen ;
Coleman, Hanna ;
Yuan, Alex ;
Duparc, Stephan ;
Green, Justin A.
作者单位：
GlaxoSmithKline Res & Dev Ltd, Global Hlth, Stockley Pk West, Uxbridge UB11 1BT, Middx, England
[1]
Parexel Int, Calif Clin Trials Med Grp, Glendale, CA USA
[2]
Wills Eye Hosp & Res Inst, Neuroophthalmol Serv, Philadelphia, PA USA
[3]
GlaxoSmithKline, Clin Res & Dev, Collegeville, PA USA
[4]
GlaxoSmithKline Res & Dev Ltd, Clin Data Management, Collegeville, PA USA
[5]
GlaxoSmithKline Res & Dev Ltd, Safety Evaluat & Risk Management, Stockley Pk West, Uxbridge, Middx
[6]
GlaxoSmithKline Res & Dev Ltd, Quantitat Sci, Stockley Pk West, Uxbridge, Middx, England
[7]
Lugene Eye Inst, Glendale, CA USA
[8]
DARC, New York, NY USA
[9]
GlaxoSmithKline, GSK Med Res Ctr, Stevenage, Herts, England
[10]
Harbor Hosp, PAREXEL, Baltimore, MD USA
[11]
IQVIA, Overland Pk, KS USA
[12]
Med Malaria Venture, Res & Dev, Geneva, Switzerland
[13]
GlaxoSmithKline, Collegeville, PA USA
[14]
Retina Specialists, Baltimore, MD USA
[15]
GlaxoSmithKline, Global Clin Safety & Pharmacovigilance, Collegeville, PA USA
[16]
发布时间
2020-02-11
换一批
